A global marketplace where futures and options on everything from interest rates and stock indexes to crops, energy, and even crypto are traded, with the CME Globex platform setting benchmarks used around the world. It began life in 1898 as the Chicago Butter and Egg Board, a regulated market for trading perishable dairy and eggs, and took its current shape through the 2007 merger of the Chicago Mercantile Exchange and the Chicago Board of Trade. Its clearing house also steps in as the buyer to every seller and seller to every buyer, helping both sides trade with confidence.
CME Group CEO Terry Duffy to become Executive Chairman; Lynne Fitzpatrick named CEO effective March 2027
Duffy will continue as CEO until the Transition Date, then serve as Executive Chairman through December 31, 2027, under a new Transition and Executive Chairman Agreement.
Show detailsHide details
On June 16, 2026, the Board approved a leadership transition: Terrence A. Duffy will become Executive Chairman, and Lynne C. Fitzpatrick will succeed him as CEO, effective on the later of March 1, 2027, or the filing of the 2026 Form 10-K.
Fitzpatrick, currently President and CFO, will become CEO and join the Board and its Executive Committee on the Transition Date; her new employment agreement sets base salary at $1.2 million, bonus opportunity at 200% of salary, and long-term incentive at 700% of salary.
The company will search for a successor to Fitzpatrick as CFO.
The transition was announced via press release on June 17, 2026.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
CME Group's 2026 Annual Meeting adjourned items voted on June 9, 2026; director election proposals failed or lacked quorum.
At the reconvened meeting, Class B-3 shares did not reach the required 33.3% quorum, so Items 6 and 8c were not presented to Class B-3 shareholders.
Show detailsHide details
CME Group Inc. held its 2026 Annual Meeting on May 14, 2026, but Items 4-8 were adjourned to June 9, 2026 due to lack of quorum among Class B-1, B-2, and B-3 shareholders.
Item 4 (eliminate Class B-1 right to elect three directors) did not pass; Class B-1 vote was 27.84% FOR, and Classes A and B vote was 80.27% FOR, but majority of outstanding Class B-1 shares was not achieved.
Item 5 (eliminate Class B-2 right to elect two directors) did not pass; Class B-2 vote was 23.37% FOR, and Classes A and B vote was 80.27% FOR, but majority of outstanding Class B-2 shares was not achieved.
Item 7 (certificate of incorporation amendment) passed with 80.29% FOR among Classes A and B, but the amendment will not be filed because its approval was contingent on Items 4, 5, and 6.
5.07 Submission of Matters to a Vote of Security Holders
CME Group 2026 annual meeting elects directors, ratifies auditor, approves executive pay; some items adjourned.
CME Group held its 2026 Annual Meeting of Shareholders on May 14, 2026, with 318,466,544 shares of Class A and B common stock present (87.78% of issued and outstanding).
Show detailsHide details
All 14 Equity Director nominees were elected to serve until the 2027 annual meeting, with votes cast by Class A and B shareholders as a single class.
The proposal to ratify Ernst & Young LLP as independent auditor for 2026 was approved with 291,376,905 votes for, 26,595,015 against, and 494,624 abstentions.
The advisory vote on named executive officer compensation was approved with 259,576,112 votes for, 34,530,288 against, and 854,319 abstentions.
Proposals under Items 4 through 8 were adjourned to a virtual meeting on June 9, 2026, because Class B-1, B-2, B-3, and B-4 shares did not reach the required quorum.
5.07 Submission of Matters to a Vote of Security Holders
CME's clearing house amends $7B 364-day credit facility, effective April 22, 2026
The amended facility is a $7 billion revolving secured credit facility, eligible to be increased to $10 billion.
Show detailsHide details
Chicago Mercantile Exchange Inc. entered into Amendment No. 11 to its 364-day multi-currency credit facility on April 22, 2026.
Proceeds may be used for temporary liquidity in cases such as clearing firm default, depositary liquidity constraints, or domestic payments system disruption.
The facility can be collateralized by clearing firm guaranty fund contributions and performance bond assets.
CME must remain in compliance with a consolidated tangible net worth test under the facility.
1.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits